[{"Assets_0_Q2_USD":165073296.0,"CommonStockSharesOutstanding_0_Q2_shares":98584371.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-56379331.0,"NetIncomeLoss_1_Q2_USD":-29387226.0,"NetIncomeLoss_2_Q2_USD":-58606488.0,"StockholdersEquity_0_Q2_USD":53616904.0,"EarningsPerShareBasic_1_Q2_USD":-0.3,"EarningsPerShareBasic_2_Q2_USD":-0.6,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":98083896.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":97795910.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]